| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0068 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |